Aprotinin but not tranexamic acid inhibits cytokine-induced inducible nitric oxide synthase expression

Anesthesia and Analgesia

Volumn 84, Issue 6, 1997, Pages 1198-1202

  Hill, Gary E ^a,c   Robbins, Richard A ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b VA NEBRASKA WESTERN IOWA HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; NITRIC OXIDE SYNTHASE; TRANEXAMIC ACID;

ANIMAL CELL; ARTICLE; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INDUCTION; ENZYME SYNTHESIS; GENE EXPRESSION REGULATION; HEART MUSCLE ISCHEMIA; MOUSE; NONHUMAN; NORTHERN BLOTTING; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROTEINASE INHIBITION; REPERFUSION INJURY;

ANIMALS; ANTIFIBRINOLYTIC AGENTS; APROTININ; BRONCHI; CELL LINE; CYTOKINES; ENZYME INDUCTION; EPITHELIUM; MICE; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXIDATION-REDUCTION; RNA, MESSENGER; SERINE PROTEINASE INHIBITORS; TRANEXAMIC ACID;

EID: 0030916994     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199706000-00005     Document Type: Article

References (28)

1. Bidstrup BP, Royston D, Sapsford RN, Taylor KM. Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol). J Thorac Cardiovasc Surg 1989; 97:364-72.
2. Horrow JC, Van Riper DF, Strong MD, et al. The dose-response relationship of tranexamic acid. Anesthesiology 1995;82:383-92.
3. Brosnan CF, Cammer W, Norton WT, Bloom BR. Proteinase inhibitors suppress the development of experimental allergic encephalomyelitis. Nature 1980;285:235-7.
4. Hunyadi J, Kenderessy AS, Duda E, et al. Platelet-activating factor antagonists (BN 52021 and BN 50730) inhibit tumor necrosis factor-alpha-mediated cytotoxicity on murine L929 tumor cells. Mol Immunol 1993;30:517-9.
5. Lord RA, Roath OS, Thompson JF, et al. Effect of aprotinin on neutrophil function after major vascular surgery. Br J Surg 1992;79:517-21.
6. Lai L, Malik AB. Effect of tranexamic acid on neutrophil superoxide anion generation. Thromb Res 1986;41:269-74.
7. Ruvolo G, Greco E, Speziale G, et al. Nitric oxide formation during cardiopulmonary bypass. Ann Thorac Surg 1994;57: 1055-6.
8. 2+-independent nitric oxide synthase activity in human lung after cardiopulmonary bypass. Thorax 1995;50:403-4.
9. Kuo H, Liu S, Barnes PJ. The effect of endogenous nitric oxide on neurogenic plasma exudation in guinea pig airways. Eur J Pharmacol 1992;221:385-8.
10. Boughton-Smith NK, Evans SM, Laszlo F, et al. The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat. Br J Pharmacol 1993;110:1189-95.
11. Alican I, Kubes P. A critical role for nitric oxide in intestinal barrier function and dysfunction. Am J Physiol 1996;270: G225-37.
12. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-12.
13. Matheis G, Sherman MP, Buckberg GD, et al. Role of L-arginine-nitric oxide pathway in myocardial reoxygenation injury. Am J Physiol 1992;262:H616-20.
14. Ignarro LJ, Fukuto JM, Griscavage JM, et al. Oxidation of nitric oxide in aqueous solution to nitrite but not nitrate: comparison with enzymatically formed nitric oxide from L-arginine. Proc Natl Acad Sci USA 1993;90:8103-7.
15. Archer SA. Measurement of nitric oxide in biologic models. FASEB J 1993;7:349-60.
16. Kim H, Lee HS, Chang KT, et al. Chloromethyl ketones block induction of nitric oxide synthase in murine macrophages by preventing activation of nuclear factor-κB. J Immunol 1995;154: 4741-8.
17. Robbins RA, Springall DR, Warren JB, et al. Inducible nitric oxide synthase is increased in murine lung epithelial cells by cytokine stimulation. Biochem Biophys Res Commun 1994;198: 835-43.
18. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
19. Xie QW, Cho HJ, Calaycay J, et al. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 1992;256:225-8.
20. Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J Biol Chem 1994;269:4705-8.
21. Berisha HI, Pakbaz H, Absood A, Said SI. Nitric oxide as a mediator of oxidant lung injury due to paraquat. Proc Natl Acad Sci USA 1994;91:1-5.
22. Ma TT, Ischiropoulos H, Brass CA. Endotoxin-stimulated nitric oxide production increases injury and reduces rat liver chemiluminescence during reperfusion. Gastroenterology 1995;108: 463-9.
23. Casey LC. Roles of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure. Ann Thorac Surg 1993;56:S92-6.
24. Hardy JF, Desroches J. Natural and synthetic antifibrinolytics in cardiac surgery. Can J Anaesth 1992;39:353-65.
25. Robbins RA, Barnes PJ, Springall DR, et al. Expression of inducible nitric oxide synthase in human lung epithelial cells. Biochem Biophys Res Commun 1994;203:209-18.
26. Herskowitz A, Choi S, Ansari AA, Wesselingh S. Cytokine mRNA expression in postischemic/reperfused myocardium. Am J Pathol 1995;146:419-28.
27. Wendel HP, Heller W, Michel J, et al. Lower cardiac tropinin T levels in patients undergoing cardiopulmonary bypass and receiving high-dose aprotinin therapy indicate reduction of perioperative myocardial damage. J Thorac Cardiovasc Surg 1995; 109:1164-72.
28. Hennein HA, Ebba H, Rodriguez JL, et al. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac Cardiovasc Surg 1994;108:626-35.